UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 413.


Abell, K; Bilancio, A; Clarkson, RW; Tiffen, PG; Altaparmakov, AI; Burdon, TG; ... Watson, CJ; + view all (2005) Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol , 7 (4) 392 - 398. 10.1038/ncb1242.

Abelman, W; Virchis, A; Yong, K; (2005) Extramedullary myeloma representing as a pericardial effusion with tamponade: two case reports and a further review of 19 cases in the literature. Leukemia and Lymphoma , 46 (1) 137 - 142.

Addison, EG; North, J; Bakhsh, I; Marden, C; Haq, S; Al-Sarraj, S; ... Lowdell, MW; + view all (2005) Ligation of CD8 alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. IMMUNOLOGY , 116 (3) 354 - 361. 10.1111/j.1365-2567.2005.02235.x. Gold open access

Aebischer, T; Bennett, CL; Pelizzola, M; Vizzardelli, C; Pavelka, N; Urbano, M; ... Ricciardi-Castagnoli, P; + view all (2005) A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana. Eur J Immunol , 35 (2) 476 - 486. 10.1002/eji.200425674.

Al-Adnani, M; Idowu, B; Yu, L; Diss, TC; Lam, L; Gale, RE; ... Flanagan, AM; + view all (2005) Detection of a new mutation in fibrous dysplasia using a modified site directed mutagenesis methodology. In: JOURNAL OF PATHOLOGY. (pp. 7 - 7). JOHN WILEY & SONS LTD

Al-Adnani, M; Idowu, B; Yu, T; Diss, TC; Gale, RE; O'Dell, E; Flanagan, AM; (2005) A simple and reliable method for the molecular diagnosis of fibrous dysplasia. In: MODERN PATHOLOGY. (pp. 10A - 11A). NATURE PUBLISHING GROUP

Alonzi, R; Hoskin, P; (2005) Novel therapies in bladder cancer. CLINICAL ONCOLOGY , 17 (7) 524 - 538.

Arce, F; Gätjens-Boniche, O; Vargas, E; Valverde, B; Díaz, C; (2005) Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett , 229 (2) 271 - 281. 10.1016/j.canlet.2005.06.047.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; ... Linch, DC; + view all (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRIT J HAEMATOL , 130 (3) 363 - 372. 10.1111/j.1365-2141.2005.05603.x.

Arkenau, H; Kubicka, S; Greil, R; Schmoll, H; Seufferlein, T; Greaven, U; ... Porschen, R; + view all (2005) Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis. EJC SUPPL , 3 (2) 168 - 168.

Arkenau, HT; Müssig, O; Buhr, T; Jend, HH; Porschen, R; (2005) Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature. Z Gastroenterol , 43 (8) 719 - 722. 10.1055/s-2005-858259.

Arkenau, HT; Rettig, K; Porschen, R; (2005) Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. Int J Colorectal Dis , 20 (3) 258 - 261. 10.1007/s00384-004-0657-6.

Arno, G; Kaski, JC; Smith, DA; Akiyu, JP; Hughes, SE; Baboonian, C; (2005) Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart , 91 (4) 521 - 525. 10.1136/hrt.2003.012054.

Attard, G; Plummer, RE; De Bono, JS; Bale, C; Fong, P; Barrett, M; ... Calvert, H; + view all (2005) Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies. In: CLINICAL CANCER RESEARCH. (pp. 9060S - 9060S). AMER ASSOC CANCER RESEARCH

Aydinok, Y; Evans, P; Terzi, A; Cetiner, N; Porter, JB; (2005) Randomised prospective evaluation of iron balance, chelation efficiency, urine excretion and NTBI progression with deferiprone (DFP) or deferoxamine (DFO) monotherapy or with combined DFP plus DFO. In: BLOOD. (pp. 758A - 758A). AMER SOC HEMATOLOGY

Azzabi, A; Hughes, AN; Calvert, PM; Plummer, ER; Todd, R; Griffin, MJ; ... Boddy, AV; + view all (2005) Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. BRIT J CANCER , 92 (6) 1006 - 1012. 10.1038/sj.bjc.6602438.


Barber, LJ; Ward, TA; Hartley, JA; McHugh, PJ; (2005) DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: Overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. MOL CELL BIOL , 25 (6) 2297 - 2309. 10.1128/MCB.25.6.2297-2309.2005. Gold open access

Bartesaghi, S; Marinovich, M; Corsini, E; Galli, CL; Viviani, B; (2005) Erythropoietin: A novel neuroprotective cytokine. NEUROTOXICOLOGY , 26 (5) 923 - 928. 10.1016/j.neuro.2005.01.016.

Basoni, C; Nobles, M; Grimshaw, A; Desgranges, C; Davies, D; Perretti, M; ... Genot, E; + view all (2005) Inhibitory control of TGF-beta 1 on the activation of Rap1, CD11b, and transendothelial migration of leukocytes. FASEB J , 19 (3) 822 - +. 10.1096/fj.04-3085fje.

Bates, AW; (2005) Emblematic monsters: unnatural conceptions and deformed births in early modern Europe. (Vol.77).

Bates, AW; (2005) Good, common, regular, and orderly: Rarly modern classifications of monstrous births. SOC HIST MED , 18 (2) 141 - 158. 10.1093/sochis/hki029.

Bates, AW; Nale, K; (2005) Segmentation defects of the human axial skeleton without dysostoses or skeletal dysplasias. FETAL PEDIATR PATHOL , 24 (2) 121 - 127. 10.1080/15227950500257333.

Bax, BE; Richfield, L; Bain, MD; Mehta, AB; Chalmers, RA; Rampling, MW; (2005) Haemorheology in Gaucher disease. European Journal of Haematology , 75 (3) 252 - 258.

Beck, S; (2005) Molecular variety club: (Epi)genetic resources for MHC/LRC-linked disease and evolution. In: TISSUE ANTIGENS. (pp. 357 - 358). BLACKWELL PUBLISHING

Bell, CG; Meyre, D; Samson, C; Boyle, C; Lecoeur, C; Tauber, M; ... Walley, AJ; + view all (2005) Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity. Diabetes , 54 (10) 3049 - 3055.

Bell, CG; Walley, AJ; Froguel, P; (2005) The genetics of human obesity. Nat Rev Genet , 6 (3) 221 - 234. 10.1038/nrg1556.

Bengala, C; Guarneri, V; Ledermann, J; Rosti, G; Wandt, H; Lotz, JP; ... EBMT Solid Tumor Working Party,; + view all (2005) High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant , 36 (1) 25 - 31. 10.1038/sj.bmt.1705007.

Benjamin, R; Streck, C; Ng, CYC; Singh, N; Khwaja, A; Pizzey, A; ... Nathwani, AC; + view all (2005) Effect of substained expression of human interferon-β by rAAV vector medicated gene transfer in xenograft models of acute leukaemia. In:

Bennett, CL; van Rijn, E; Jung, S; Inaba, K; Steinman, RM; Kapsenberg, ML; Clausen, BE; (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol , 169 (4) 569 - 576. 10.1083/jcb.200501071. Green open access

Bentzen, SM; Atasoy, BM; Daley, FM; Dische, S; Richman, PI; Saunders, MI; ... Wilson, GD; + view all (2005) Epidermal growth factor receptor expression in pre-treatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomised controlled trial. Journal of Clinical Oncology , 23 (24) 5560 - 5567. 10.1200/jco.2005.06.411.

Beresford, M; Glynne-Jones, R; Richman, P; Makris, A; Mawdsley, S; Stott, D; ... Harrison, RA; + view all (2005) The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. CLINICAL ONCOLOGY , 17 (6) 448 - 455.

Beresford, M; Padhani, AR; Goh, V; Makris, A; (2005) Imaging breast cancer response during neoadjuvant systemic therapy. Expert Review of Anticancer Therapy , 5 (5) 893 - 905.

Betticher, D; von Rohr, A; Kovacsovics, T; Martinelli, G; Cerny, T; Linch, DC; ... Cina, S; + view all (2005) Sequential high-dose chemotherapy (SHDC) with autologous stem cell transplantation (ASCT) vs standard CHOP regimen for pts with untreated aggressive NHL. Result of the mistral trial from the Swiss Group for Clinical Cancer Research (SAKK). In: ANNALS OF ONCOLOGY. (pp. 100 - 101). OXFORD UNIV PRESS

Bloor, AJC; Thomson, K; Cooper, N; Peggs, KS; Mackinnon, S; (2005) Dose-escalated donor lymphocyte infusions post allogeneic transplantation in non-Hodgkin's lymphoma. In: BLOOD. (pp. 569A - 570A). AMER SOC HEMATOLOGY

Boddy, AV; Plummer, ER; Todd, R; Sludden, J; Griffin, M; Robson, L; ... Calvert, AH; + view all (2005) A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules. CLIN CANCER RES , 11 (21) 7834 - 7840. 10.1158/1078-0432.CCR-05-0803.

Bose, F; Fugazza, C; Capelli, A; Ronzoni, L; Cappellini, MD; Jane, S; ... Ronchi, A; + view all (2005) Functional interaction of CP2 with GATA-1 in the regulation of the expression of erythroid promoters. In: BLOOD CELLS MOLECULES AND DISEASES. (pp. 119 - 120). ACADEMIC PRESS INC ELSEVIER SCIENCE

Bowen, DT; Frew, ME; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; ... Linch, DC; + view all (2005) RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. BLOOD , 106 (6) 2113 - 2119. 10.1182/blood-2005-03-0867.

Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; ... Stebbing, J; + view all (2005) A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. ANN INTERN MED , 143 (4) 265 - 273.

Bower, M; Nelson, M; Young, AM; Thirlwell, C; Newsom-Davis, T; Mandalia, S; ... Stebbing, J; + view all (2005) Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J CLIN ONCOL , 23 (22) 5224 - 5228. 10.1200/JCO.2005.14.597.

Bower, M; Powles, T; Stebbing, J; Thirlwell, C; (2005) Potential antiretroviral drug interactions with cyclophosphamide, doxorubicin, and etoposide. J CLIN ONCOL , 23 (6) 1328 - 1329. 10.1200/JCO.2005.05.128.

Boxer, GM; Tsiompanou, E; Levine, T; Watson, R; Begent, RHJ; (2005) Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. TUMOR BIOL , 26 (1) 1 - 8. 10.1159/000084180.

Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JP; ... Young, RA; + view all (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell , 122 (6) 947 - 956. 10.1016/j.cell.2005.08.020.

Braybrooke, JP; Slade, A; Deplanque, G; Harrop, R; Madhusudan, S; Forster, MD; ... Harris, AL; + view all (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. Clin Cancer Res , 11 (4) 1512 - 1520. 10.1158/1078-0432.CCR-04-0155.

Brenner, C; Deplus, R; Didelot, C; Loriot, A; Vire, E; De Smet, C; ... Fuks, F; + view all (2005) Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J , 24 (2) 336 - 346. 10.1038/sj.emboj.7600509.

Brooks, S; Bownes, P; Lowe, G; Bryant, L; Hoskin, PJ; (2005) Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. International Journal of Radiation Oncology Biology Physics , 63 (3) 934 - 939.

Brown, P; Marafioti, T; Kusec, R; Banham, AH; (2005) The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma. J Mol Histol , 36 (4) 249 - 256. 10.1007/s10735-005-6521-3.

Buchmueller, KL; Taherbhai, Z; Howard, CM; Bailey, SL; Nguyen, B; O'Hare, C; ... Lee, M; + view all (2005) Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multildrug resistant (MDR1) gene. CHEMBIOCHEM , 6 (12) 2305 - 2311. 10.1002/cbic.200500179.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; ... Linch, D; + view all (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. Br J Haematol , 130 (4) 536 - 541. 10.1111/j.1365-2141.2005.05640.x.

Butcher, LM; Meaburn, E; Dale, PS; Sham, P; Schalkwyk, LC; Craig, IW; Plomin, R; (2005) Association analysis of mild mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Mol.Psychiatry , 10 (4) 384 - 392. 10.1038/sj.mp.4001589.

Butcher, LM; Meaburn, E; Knight, J; Sham, PC; Schalkwyk, LC; Craig, IW; Plomin, R; (2005) SNPs, microarrays and pooled DNA: identification of four loci associated with mild mental impairment in a sample of 6000 children. Hum.Mol.Genet. , 14 (10) 1315 - 1325. 10.1093/hmg/ddi142.


Cairo, S; De Falco, F; Pizzo, M; Salomoni, P; Pandolfi, PP; Meroni, G; (2005) PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. ONCOGENE , 24 (13) 2195 - 2203. 10.1038/sj.onc.1208338.

Calvert, AH; (2005) Fishing for new drugs. J CLIN ONCOL , 23 (31) 7780 - 7782. 10.1200/JCO.2005.08.004.

Calvert, H; Twelves, C; Ranson, M; Anthoney, A; Plummer, R; Fettner, S; ... Rakhit, A; + view all (2005) The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 210S - 210S). AMER SOC CLINICAL ONCOLOGY

Camilleri, RS; Cohen, H; (2005) No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism. BLOOD COAGUL FIBRIN , 16 (3) 193 - 198.

Camilleri, RS; Mackie, IJ; Scully, M; Machin, SJ; Cohen, H; (2005) A genetic basis for adult onset TTP? In: BLOOD. (pp. 357A - 357A). AMER SOC HEMATOLOGY

Capponcelli, S; Pedrini, E; Cerone, MA; Corti, V; Fontanesi, S; Alessio, M; ... Sangiorgi, L; + view all (2005) Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat , 26 (2) 94 - 103. 10.1002/humu.20192.

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The Quality of Fresh-Frozen Plasma (FFP) Produced from Whole Blood Stored at 4°C Overnight. Transfusion , 45 1342 - 1348.

Carroll, VA; Nikitenko, LL; Bicknell, R; Harris, AL; (2005) Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2. ARTERIOSCL THROM VAS , 25 (4) 736 - 741. 10.1161/01.ATV.0000157980.15710.2b.

Casely-Hayford, MA; Pors, K; James, CH; Patterson, LH; Hartley, JA; Searcey, M; (2005) Design and synthesis of a DNA-crosslinking azinomycin analogue. ORG BIOMOL CHEM , 3 (19) 3585 - 3589. 10.1039/b508908e.

Cerone, MA; Autexier, C; Londoño-Vallejo, JA; Bacchetti, S; (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene , 24 (53) 7893 - 7901. 10.1038/sj.onc.1208934.

Cerone, MA; Ward, RJ; Londoño-Vallejo, JA; Autexier, C; (2005) Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle , 4 (4) 585 - 589.

Charrier, S; Stockholm, D; Seye, K; Opolon, P; Taveau, M; Gross, DA; ... Galy, A; + view all (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther , 12 (7) 597 - 606. 10.1038/sj.gt.3302440.

Chatterjee, R; Shah, F; Davis, B; Byers, DM; Sooranna, S; Bajoria, R; ... Porter, JB; + view all (2005) Prospective study of histomormometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteoporosis. In: JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION. (pp. 375A - 376A). ELSEVIER SCIENCE INC

Chen-Scarabelli, C; Hughes, SE; Landon, G; Rowley, P; Allebban, Z; Lawson, N; ... Scarabelli, TM; + view all (2005) A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. EUR J HEART FAIL , 7 (5) 927 - 930. 10.1016/j.ejheart.2004.09.012.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshina, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin's lymphoma: A questionnaire-based survey evaluating current practice in the United Kingdom. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 26 - 27). BLACKWELL PUBLISHING

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. BRIT J HAEMATOL , 131 (2) 193 - 200. 10.1111/j.1365-2141.2005.05756.x.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK (vol 131, pg 193, 2005). BRIT J HAEMATOL , 131 (5) 673 - 673.

Cholongitas, E; Quaglia, A; Samonakis, D; Senzolo, M; Triantos, CK; Patch, D; ... Burroughs, AK; + view all (2005) Transjugular liver biopsy: Is it effective for accurate histological interpretation? In: GUT. (pp. A26 - A26). B M J PUBLISHING GROUP

Clarke, DL; Belvisi, MG; Smith, SJ; Hardaker, E; Yacoub, MH; Meja, KK; ... Giembycz, MA; + view all (2005) Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol , 288 (2) L238 - L250. 10.1152/ajplung.00313.2004.

Cleator, SJ; Makris, A; Ashley, SE; Lal, R; Powles, TJ; (2005) Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology , 16 (2) 267 - 272.

Clingen, PH; De Silva, IU; McHugh, PJ; Ghadessy, FJ; Tilby, MJ; Thurston, DE; Hartley, JA; (2005) The XPF-ERCC1 endonuclease and homologous recon bination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. NUCLEIC ACIDS RES , 33 (10) 3283 - 3291. 10.1093/nar/gki639. Gold open access

Coakley, M; Self, R; Marchant, W; Mackie, I; Mallett, SV; Mythen, M; (2005) Use of the platelet function analyser (PFA-100 (R)) to quantify the effect of low dose aspirin in patients with ischaemic heart disease. ANAESTHESIA , 60 (12) 1173 - 1178. 10.1111/j.1365-2044.2005.04291.x.

Cobbold, M; Khan, N; Pourgheysari, B; Tauro, S; McDonald, D; Osman, H; ... Moss, PAH; + view all (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J EXP MED , 202 (3) 379 - 386. 10.1084/jem.20040613.

Cohen, H; (2005) Inherited thrombophilia and pregnancy loss-epidemiology. THROMBOSIS RESEARCH , 115 13 - 17.

Cohen, H; Scully, M; Starke, R; Mackie, I; Machin, S; (2005) Successful pregnancy outcome of three patients with chronic, unremitting Thrombotic Thrombocytopenic Purpura. In: THROMBOSIS RESEARCH. (pp. 116 - 116). PERGAMON-ELSEVIER SCIENCE LTD

Collin, MP; Hart, DN; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; Dickinson, AM; (2005) The fate of human Langerhans cells in hematopoietic stem cell transplantation. In: BLOOD. (pp. 170A - 170A). AMER SOC HEMATOLOGY

Condliffe, AM; Davidson, K; Anderson, KE; Ellson, CD; Crabbe, T; Okkenhaug, K; ... Hawkins, PT; + view all (2005) Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. BLOOD , 106 (4) 1432 - 1440. 10.1182/blood-2005-03-0944.

Conti, L; Pollard, SM; Gorba, T; Reitano, E; Toselli, M; Biella, G; ... Smith, A; + view all (2005) Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biology , 3 (9) , Article e283 . 10.1371/journal.pbio.0030283. Green open access

Cooper, N; Avivi, I; Karl, PS; Hart, DQ; Thomson, K; Bloor, AJC; ... Mackinnon, S; + view all (2005) The use of PET scans to direct immunotherapy following reduced intensity stem cell transplants in adults with lymphoid malignancies. In: BLOOD. (pp. 438B - 438B). AMER SOC HEMATOLOGY

Crawley, C; Lalancette, M; Szydlo, R; Gilleece, M; Peggs, K; Mackinnon, S; ... Chronic Leukaemia Working Party EB,; + view all (2005) Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. BLOOD , 105 (11) 4532 - 4539. 10.1182/blood-2004-06-2387.

Cross, JGR; Harrison, GA; Coggill, P; Sims, S; Beck, S; Deakin, JE; Graves, JAM; (2005) Analysis of the genomic region containing the tammar wallaby (Macropus eugenii) orthologues of MHC class III genes. CYTOGENET GENOME RES , 111 (2) 110 - 117. 10.1159/000086379.

Crowther, DC; Kinghorn, KJ; Miranda, E; Page, R; Curry, JA; Duthie, FA; ... Lomas, DA; + view all (2005) Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience , 132 (1) 123 - 135. 10.1016/j.neuroscience.2004.12.025.

Cuomo, ME; Knebel, A; Platt, G; Morrice, N; Cohen, P; Mittnacht, S; (2005) Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin.CDK6 phosphorylation of caldesmon. J Biol Chem , 280 (43) 35844 - 35858. 10.1074/jbc.M503877200. Gold open access

Cutillas, PR; Geering, B; Waterfield, MD; Vanhaesebroeck, B; (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol Cell Proteomics , 4 (8) 1038 - 1051. 10.1074/mcp.M500078-MCP200.


Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; ... Lee, M; + view all (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. BIOORG MED CHEM LETT , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; ... Lee, M; + view all (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorg Med Chem Lett , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Dark, GG; Calvert, AH; Grimshaw, R; Poole, C; Swenerton, K; Kaye, S; ... Eisenhauer, EA; + view all (2005) Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group. JOURNAL OF CLINICAL ONCOLOGY , 23 (9) 1859 - 1866. 10.1200/JCO.2005.02.028.

Davidoff, AM; Gray, JT; Ng, CYC; Zhang, YB; Zhou, JF; Spence, Y; ... Nathwani, AC; + view all (2005) Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. MOL THER , 11 (6) 875 - 888. 10.1016/j.ymthe.2004.12.022.

Davidoff, AM; Ng, CYC; Zhang, YB; Streck, CJ; Mabry, SJ; Barton, SH; ... Nathwani, AC; + view all (2005) Careful decoy receptor titering is required to inhibit tumor angiogenesis while avoiding adversely altering VEGF bioavailability. MOL THER , 11 (2) 300 - 310. 10.1016/j.ymthe.2004.09.014.

Davies, H; Hunter, C; Smith, R; Stephens, P; Greenman, C; Bignell, G; ... Futreal, PA; + view all (2005) Somatic mutations of the protein kinase gene family in human lung cancer. CANCER RES , 65 (17) 7591 - 7595. 10.1158/0008-5472.CAN-05-1855.

de Bruin, EC; van de Pas, S; Lips, EH; van Eijk, R; van der Zee, MM; Lombaerts, M; ... Peltenburg, LT; + view all (2005) Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics , 6 , Article 142 . 10.1186/1471-2164-6-142. Green open access

de Groot, NG; Garcia, CA; Verschoor, EJ; Doxiadis, GG; Marsh, SGE; Otting, N; Bontrop, RE; (2005) Reduced MIC gene repertoire variation in West African chimpanzees as compared to humans. Molecular Biology and Evolution , 22 (6) 1375 - 1385.

Deakin, JE; Papenfuss, AT; Cross, JGR; Belov, K; Coghill, P; Palmer, S; ... Graves, JAM; + view all (2005) Comparative analysis and evolution of the MHC class III region. In: TISSUE ANTIGENS. (pp. 395 - 395). BLACKWELL PUBLISHING

Dearling, JLJ; Flynn, AA; Beken, L; Petrie, IA; El-Emir, E; Boxer, GM; ... Pedley, RB; + view all (2005) Dose Estimation in a 3D Tumour Reconstruction -Impact of the Heterogeneity of TumourPathophysiology on RIT and EBRT. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. (pp. S83 - S83).

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2005) Radioimmunotherapy Combined with Anti-Hypoxia Therapy 2DG Results in Reduction of Therapeutic Efficacy. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. (pp. S48 - S48).

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, GM; Begent, RHJ; Pedley, RB; (2005) Analysis of Antibody Distribution Reveals Higher Uptake in Peripheral Intrahepatic Deposits Than Central Deposits. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. (pp. S83 - S83).

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; ... Milligan, D; + view all (2005) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukemia: A BSBMT study. In: BLOOD. (pp. 813A - 813A). AMER SOC HEMATOLOGY

Dhami, P; Coffey, AJ; Abbs, S; Vermeesch, JR; Dumanski, JP; Woodward, KJ; ... Vetrie, D; + view all (2005) Exon array CGH: Detection of copy-number changes at the resolution of individual exons in the human genome. AM J HUM GENET , 76 (5) 750 - 762.

Dickson, PV; Nathwani, AC; Davidoff, AM; (2005) Delivery of antiangiogenic agents for cancer gene therapy. TECHNOL CANCER RES T , 4 (4) 331 - 341.

Diss, TC; Berisha, F; Lam, L; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time PCR. In: LABORATORY INVESTIGATION. (pp. 13A - 13A). NATURE PUBLISHING GROUP

Diss, TC; Berisha, F; Lam, L; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time PCR. In: MODERN PATHOLOGY. (pp. 13A - 13A). NATURE PUBLISHING GROUP

Diss, TC; Lam, L; Berisha, F; Flanagan, AM; (2005) A real-time RT-PCR method for detection of EWS/ATF1 fusion transcripts in clear cell sarcoma using paraffin-embedded material. In: JOURNAL OF PATHOLOGY. (pp. 53 - 53). JOHN WILEY & SONS LTD

Diss, TC; Lam, L; Berisha, F; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time RT-PCR. In: JOURNAL OF PATHOLOGY. (pp. 54 - 54). JOHN WILEY & SONS LTD

Dogan, A; Du, M-Q; Isaacson, PG; (2005) A relapsing inflammatory syndrome and HHV-8. The New England Journal of Medicine , 353 (16) 1746 - 1747. 10.1056/NEJMc052161. Green open access

Dotti, G; Savoldo, B; Pule, M; Straathof, KC; Biagi, E; Yvon, E; ... Rooney, CM; + view all (2005) lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. BLOOD , 105 (12) 4677 - 4684. 10.1182/blood-2004-08-3337. Green open access

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, A; Patch, D; ... Quaglia, AFE; + view all (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. BIOL BLOOD MARROW TR , 11 (10) 805 - 813. 10.1016/j.bbmt.2005.06.008.

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, M; Patch, D; ... Quaglia, AF; + view all (2005) Histological features in the liver biopsy predict the clinical outcome of patients with graft-versus-host disease of the liver. In: BONE MARROW TRANSPLANTATION. (pp. S43 - S43). NATURE PUBLISHING GROUP

Dudderidge, TJ; Haynes, SV; Davies, AJ; Jarmulowicz, M; Al-Akraa, MA; (2005) Vesicocervical fistula: rare complication of cesarean section demonstrated by magnetic resonance imaging. Urology , 65 (1) 174 - ?. 10.1016/j.urology.2004.07.001.


Eguchi, M; Eguchi-Ishimae, M; Green, A; Enver, T; Greaves, M; (2005) Directing oncogenic fusion genes into stem cells via an SCL enhancer. P NATL ACAD SCI USA , 102 (4) 1133 - 1138. 10.1073/pnas.0405318102.

El-Emir, E; Boxer, GM; Petrie, IA; Boden, RW; Dearling, JLJ; Begent, RHJ; Pedley, RB; (2005) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. EUR J CANCER , 41 (5) 799 - 806. 10.1016/j.ejca.2005.01.001.

Enver, T; Huang, S; (2005) Mathematical modeling of transcriptional regulatory circuits defines cell fate attractors and predicts the genome-scale behaviour of haemopoietic progenitor cells undergoing a binary cell fate decision. In: BLOOD. (pp. 135B - 135B). AMER SOC HEMATOLOGY

Enver, T; Soneji, S; Joshi, C; Brown, J; Iborra, F; Orntoft, T; ... Andrews, PW; + view all (2005) Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. HUM MOL GENET , 14 (21) 3129 - 3140. 10.1093/hmg/ddi345.

Enver, T; Tsuzuki, S; Brown, J; Hong, DL; Gupta, R; Ford, T; ... Greaves, M; + view all (2005) Developmental impact of leukemic fusion genes on stem cell fate. HEMATOPOIETIC STEM CELLS V , 1044 16 - 23. 10.1196/annals.1349.003.

Ezoe, S; Matsumura, I; Gale, K; Satoh, Y; Ishikawa, J; Mizuki, M; ... Kanakura, Y; + view all (2005) GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J BIOL CHEM , 280 (13) 13163 - 13170. 10.1074/jbc.M413461200. Gold open access


Field, D; Feil, EJ; Wilson, GA; (2005) Databases and software for the comparison of prokaryotic genomes. Microbiology , 151 (Pt 7) 2125 - 2132.

Fielding, AK; (2005) Measles as a potential oncolytic virus. REV MED VIROL , 15 (2) 135 - 142. 10.1002/rmv.455.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; Brit Soc Haematology Taskforce Hae,; (2005) An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. BRIT J HAEMATOL , 131 (2) 156 - 165. 10.1111/j.1365-2141.2005.05739.x.

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Gerrard, G; Patel, B; ... Goldstone, AH; + view all (2005) Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Patel, B; Richards, S; ... Goldstone, AH; + view all (2005) Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 424A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Richards, S; Fielding, A; Goldstone, AH; (2005) The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; Khaliq, S; Pasha, S; Willis, C; Abbasi, R; ... Maher, ER; + view all (2005) Locus heterogeneity in autosomal recessive congenital cataracts: linkage to 9q and germline HSF4 mutations. HUM GENET , 117 (5) 452 - 459. 10.1007/s00439-005-1309-9.

Forshew, T; Khaliq, S; Tee, L; Smith, U; Johnson, CA; Mehdi, SQ; Maher, ER; (2005) Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism. Clin Genet , 68 (2) 182 - 184. 10.1111/j.1399-0004.2005.00460.x.

Freeman, L; Hewison, M; Hughes, SV; Evans, KN; Hardie, D; Means, TK; Chakraverty, R; (2005) Expression of 11 beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. BLOOD , 106 (6) 2042 - 2049. 10.1182/blood-2005-01-0186.


Gale, RE; Hills, R; Kottaridis, PD; Srirangan, S; Wheatley, K; Burnett, AK; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials. BLOOD , 106 (10) 3658 - 3665. 10.1182/blood-2005-03-1323. Green open access

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; ... NCRI Adult Leukaemia Working Party,; + view all (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. BLOOD , 106 (12) 3768 - 3776. Green open access

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; ... Grimwade, DNCRIALWP; + view all (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood , 106 (12) 3768 - 3776. 10.1182/blood-2005-04-1746.

Galluzzi, L; Pinti, M; Guaraldi, G; Mussini, C; Troiano, L; Roat, E; ... Cossarizza, A; + view all (2005) Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir Ther , 10 Suppl 2 M91 - M99.

Galluzzi, L; Pinti, M; Troiano, L; Prada, N; Nasi, M; Ferraresi, R; ... Cossarizzo, A; + view all (2005) Changes in mitochondrial RNA production in cells treated with nucleoside analogues. ANTIVIR THER , 10 (1) 191 - 195.

Ganeshaguru, K; Folarin, NI; Baker, RJ; Casanova, AM; Bhimjiyani, A; Hoffbrand, AV; ... Wickremasinghe, RG; + view all (2005) An in vitro model of proliferating CLL cells for drug sensitivity analysis. In: BLOOD. (pp. 829A - 829A). AMER SOC HEMATOLOGY

Gardiner, C; Pennaneac'h, C; Walford, C; Machin, SJ; Mackie, IJ; (2005) An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. BRIT J HAEMATOL , 128 (6) 842 - 848. 10.1111/j.1365-2141.2005.05394.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. BRIT J HAEMATOL , 128 (2) 242 - 247. 10.1111/j.1365.2141.2004.05300.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol , 128 (2) 242 - 247. 10.1111/j.1365-2141.2004.05300.x.

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 11 - 11). BLACKWELL PUBLISHING

Garrett, MD; Mittnacht, S; (2005) Editorial overview: The genetics and biology of cancer - revealing avenues for therapy. CURRENT OPINION IN GENETICS & DEVELOPMENT , 15 (1) 1 - 4. 10.1016/j.gde.2004.12.012.

Garrett, MD; Mittnacht, S; (2005) Oncogenes and cell proliferation: The genetics and biology of cancer - Revealing avenues for therapy. Current Opinion in Genetics and Development , 15 (1) 1 - 4. 10.1016/j.gde.2004.12.012.

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, A; (2005) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. European Journal of Pharmacology , 609 (1-3) 34 - 39.

Gibbs, DD; Theti, DS; Wood, N; Green, M; Raynaud, F; Valenti, M; ... Jackman, AL; + view all (2005) BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Cancer Res , 65 (24) 11721 - 11728. 10.1158/0008-5472.CAN-05-2034.

Glasow, A; Barrett, A; Gupta, R; Grimwade, D; von Lindern, M; Enver, T; Zelent, A; (2005) Expression of ATRA inducible RAR alpha 2 isoform is deregulated in AML. In: BLOOD. (pp. 351A - 351A). AMER SOC HEMATOLOGY

Gomez-Escobar, N; Bennett, C; Prieto-Lafuente, L; Aebischer, T; Blackburn, CC; Maizels, RM; (2005) Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function. BMC Biology , 3 , Article 108. 10.1186/1741-7007-3-8. Green open access

Gondek, DC; Lu, LF; Quezada, SA; Sakaguchi, S; Noelle, RJ; (2005) Cutting edge: Contact-mediated suppression by CD4(+)-CD25(+) regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J IMMUNOL , 174 (4) 1783 - 1786.

Grandage, VL; Gale, RE; Linch, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappa B, MAPkinase and p53 pathways. LEUKEMIA , 19 (4) 586 - 594. 10.1038/sj.leu.2403653.

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976 is a novel and potent inhibitor of JAK2 and JAK3 tyrosine kinases both in vitro and in cellular assays. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 6 - 6). BLACKWELL PUBLISHING

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976, a novel and potent inhibitor of JAK2 and JAK3, reduces constitutive STAT activity and induces apoptosis in myeloid leukaemia and anaplastic lymphoma cells. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 40 - 40). BLACKWELL PUBLISHING

Gregg, R; Smith, CM; Clark, FJ; Dunnion, D; Khan, N; Chakraverty, R; ... Moss, PA; + view all (2005) The number of human peripheral blood CD4(+) CD25(high) regulatory T cells increases with age. CLIN EXP IMMUNOL , 140 (3) 540 - 546. 10.1111/j.1365-2249.2005.02798.x.

Guérardel, A; Barat-Houari, M; Vasseur, F; Dina, C; Vatin, V; Clément, K; ... Froguel, P; + view all (2005) Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet , 6 19 - ?. 10.1186/1471-2156-6-19. Gold open access

Guenther, MG; Jenner, RG; Chevalier, B; Nakamura, T; Croce, CM; Canaani, E; Young, RA; (2005) Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A , 102 (24) 8603 - 8608. 10.1073/pnas.0503072102.

Guest, RD; Hawkins, RE; Kirillova, N; Cheadle, EJ; Arnold, J; O'Neill, A; ... Gilham, DE; + view all (2005) The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens. J IMMUNOTHER , 28 (3) 203 - 211.


Haines, BP; Gupta, R; Jones, CM; Summerbell, D; Rigby, PW; (2005) The NLRR gene family and mouse development: Modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts. Developmental Biology , 281 (2) 145 - 159. 10.1016/j.ydbio.2005.01.030.

Hardcastle, IR; Ahmed, SU; Atkins, H; Calvert, AH; Curtin, NJ; Farnie, G; ... Lunec, J; + view all (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. BIOORG MED CHEM LETT , 15 (5) 1515 - 1520. 10.1016/j.bmcl.2004.12.061.

Harlaar, N; Butcher, LM; Meaburn, E; Sham, P; Craig, IW; Plomin, R; (2005) A behavioural genomic analysis of DNA markers associated with general cognitive ability in 7-year-olds. J.Child Psychol.Psychiatry , 46 (10) 1097 - 1107. 10.1111/j.1469-7610.2005.01515.x.

Harrison, CN; et, A; (2005) Hydroxyurea compared with anegralide in high risk essential thrombocythaemia. New England Journal of Medicine , 353 (1) 33 - 45.

Hartley, JA; Hochhauser, D; Lee, M; Howard, PW; Thurston, DE; (2005) DNA targeting with PBD and polyamide-based agents. In: CLINICAL CANCER RESEARCH. (pp. 9176S - 9176S). AMER ASSOC CANCER RESEARCH

Hartmann, G; Vassileva, V; Piquette-Miller, M; (2005) Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. DRUG METAB DISPOS , 33 (6) 820 - 828. 10.1124/dmd.104.002568.

Hergovich, A; Bichsel, SJ; Hemmings, BA; (2005) Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation. MOL CELL BIOL , 25 (18) 8259 - 8272. 10.1128/MCB.25.18.8259-8272.2005.

Hing, KA; Annaz, B; Saeed, S; Revell, PA; Buckland, T; (2005) Microporosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci Mater Med , 16 (5) 467 - 475. 10.1007/s10856-005-6988-1.

Ho, EA; Vassileva, V; Allen, C; Piquette-Miller, M; (2005) In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. J CONTROL RELEASE , 104 (1) 181 - 191. 10.1016/j.jconrel.2005.02.008.

Hoskin, PJ; (2005) Palliative radiotherapy for non-small-cell lung cancer: Which dose? ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Radioisotopes for metastatic bone pain. LANCET LTD, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; Rojas, AM; Phillips, H; Saunders, MI; (2005) Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. Cancer , 103 (11) 2287 - 2297. 10.1002/cncr.21048.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; ... British Natl Lymphoma Invest,; + view all (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLIN ONCOL-UK , 17 (1) 47 - 53. 10.1016/j.clon.2004.07.004.

Howard, PW; Chen, ZZ; Gregson, SJ; Stephenson, M; Klee, S; Hartley, J; ... Thurston, DE; + view all (2005) Design, synthesis and biological evaluation of ZC-423, a novel C2-aryl substituted pyrrolobenzodiazepine PBD) dimer. In: CLINICAL CANCER RESEARCH. (pp. 9015S - 9016S). AMER ASSOC CANCER RESEARCH

Howie, AJ; Pankhurst, T; Sarioglu, S; Turhan, N; Adu, D; (2005) Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int , 67 (3) 987 - 1001. 10.1111/j.1523-1755.2005.00162.x.

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. In: ACTA PAEDIATRICA. (pp. 28 - 33). TAYLOR & FRANCIS AS

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatr Suppl , 94 (447) 28 - 33.

Hughes, SE; McKenna, WJ; (2005) New insights into the pathology of inherited cardiomyopathy. HEART , 91 (2) 257 - 264. 10.1136/hrt.2004.040337. Gold open access

Hunter, HM; Peggs, K; Powles, R; Rahemtulla, A; Mahendra, P; Cavenagh, J; ... Clinical Trials Comm British Soc,; + view all (2005) Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation. BRIT J HAEMATOL , 128 (4) 496 - 502. 10.1111/j.1365-2141.2004.05330.x.


Ishiko, E; Matsumura, I; Ezoe, S; Gale, K; Ishiko, J; Satoh, Y; ... Kanakura, Y; + view all (2005) Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J BIOL CHEM , 280 (6) 4929 - 4939. 10.1074/jbc.M406788200. Gold open access


Jacobs, EMG; Hendriks, JCM; van Tits, BLJH; Evans, PJ; Breuer, W; Liu, DY; ... Swinkels, DW; + view all (2005) Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. ANAL BIOCHEM , 341 (2) 241 - 250. 10.1016/j.ab.2005.03.008.

Jenner, RG; Young, RA; (2005) Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol , 3 (4) 281 - 294. 10.1038/nrmicro1126.

Jenny, C; Toublanc, E; Danos, O; Merten, OW; (2005) Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells. Cytotechnology , 49 (1) 11 - 23. 10.1007/s10616-005-5361-z.

Jewell, AP; Cochrane, M; McIntosh, J; Benjamin, R; Nathwani, A; (2005) Comparison of viral vectors for gene transfer into CLL cells: Efficient transduction with adeno-associated virus-8 (AAV-8). In: BLOOD. (pp. 837A - 837A). AMER SOC HEMATOLOGY


Kanhere, A; Bansal, M; (2005) A novel method for prokaryotic promoter prediction based on DNA stability. BMC BIOINFORMATICS , 6 , Article 1. 10.1186/1471-2105-6-1. Green open access

Kanhere, A; Bansal, M; (2005) Structural properties of promoters: similarities and differences between prokaryotes and eukaryotes. NUCLEIC ACIDS RES , 33 (10) 3165 - 3175. 10.1093/nar/gki627. Gold open access

Ke, XY; Miretti, MM; Broxholme, J; Hunt, S; Beck, S; Bentley, DR; ... Cardon, LR; + view all (2005) A comparison of tagging methods and their tagging space. HUM MOL GENET , 14 (18) 2757 - 2767. 10.1093/hmg/ddi309.

Kenny, PA; Enver, T; Ashworth, A; (2005) Receptor and secreted targets of Wnt-I/beta-catenin signalling in mouse mammary epithelial cells. BMC Cancer , 5 , Article 3. 10.1186/1471-2407-5-3. Green open access

Khelifi, AF; D'Alcontres, MS; Salomoni, P; (2005) Daxx is required for stress-induced cell death and JNK activation. CELL DEATH DIFFER , 12 (7) 724 - 733. 10.1038/sj.cdd.4401559.

Kindle, KB; Troke, PJF; Collins, HM; Matsuda, S; Bossi, D; Bellodi, C; ... Heery, DM; + view all (2005) MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. MOL CELL BIOL , 25 (3) 988 - 1002. 10.1128/MCB.25.3.988-1002.2005.

King-Underwood, L; Little, S; Baker, M; Clutterbuck, R; Delassus, S; Enver, T; ... Pritchard-Jones, K; + view all (2005) Wt1 is not essential for hematopoiesis in the mouse. LEUKEMIA RES , 29 (7) 803 - 812. 10.1016/j.leukres.2004.11.020.

Kirk, P; Firmin, DN; Sampson, B; Porter, JB; Walker, MJ; Pennell, DJ; (2005) Validation of T2*technique in ex-vivo myocardial tissue. In: BLOOD. (pp. 7B - 7B). AMER SOC HEMATOLOGY

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; ... Sunder-Plassmann, G; + view all (2005) Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey. Kidney International , 67 (5) 1955 - 1960.

Knoll, N; Ruhe, C; Veeriah, S; Sauer, J; Glei, M; Gallagher, EP; Pool-Zobel, BL; (2005) Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol Sci , 86 (1) 27 - 35. 10.1093/toxsci/kfi171.

Kocjan, G; (2005) Cytological and molecular diagnosis of lymphoma. J CLIN PATHOL , 58 (6) 561 - 567. 10.1136/jcp.2004.019133.

Kocjan, G; Priollet, BC; Desai, M; Koutselini, H; Mahovlic, V; Oliveira, MH; ... Herbert, A; + view all (2005) BSCC, Bethesda or other? Terminology in cervical cytology European panel discussion. CYTOPATHOLOGY , 16 (3) 113 - 119.

Kogelberg, H; Tolner, B; Lowdell, M; Qureshi, U; Robson, M; Dearling, JL; ... Chester, KA; + view all (2005) Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP. In: (Proceedings) NCRI Cancer Conference Proceedings.

Kotecha, M; O'Hare, C; Wells, G; Howard, P; Thurston, D; Mantovani, R; ... Hochhauser, D; + view all (2005) Inhibition of DNA binding of the transcription factor complex NF-Y by a pyrrolobenzodiazepine-polyamide conjugate. In: CLINICAL CANCER RESEARCH. (pp. 9016S - 9016S). AMER ASSOC CANCER RESEARCH

Kröger, N; Zabelina, T; Ayuk, F; Zander, AR; Shaw, B; Madrigal, A; ... Marks, DI; + view all (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. British Journal of Haematology , 129 (5) 631 - 643. 10.1111/j.1365-2141.2005.05513.x.

Krützfeldt, M; Ellis, M; Weekes, DB; Bull, JJ; Eilers, M; Vivanco, MD; ... Mittnacht, S; + view all (2005) Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell , 18 (2) 213 - 224. 10.1016/j.molcel.2005.03.009.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; ... German Cooperative Transplant Grp,; + view all (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. BRIT J HAEMATOL , 129 (5) 631 - 643. 10.1111/j.1365-2141.2005.05513.x.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; ... Marks, D; + view all (2005) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated SCT in patients with multiple myeloma. In: BONE MARROW TRANSPLANTATION. (pp. S49 - S49). NATURE PUBLISHING GROUP

Kulkarni, S; Davies, AJW; Treurnicht, K; Dudderidge, TJ; Al-Akraa, M; (2005) Misplaced Macroplastique injection presenting as a vaginal nodule and a bladder mass. INT J CLIN PRACT , 59 85 - 86.

Kyriakou, C; Thomson, K; D'Sa, S; Flory, A; Hanslip, J; Goldstone, AH; Yong, KL; (2005) Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma. BRIT J HAEMATOL , 129 (6) 763 - 770. 10.1111/j.1365-2141.2005.05521.x.


Lam, L; Diss, TC; Berisha, F; Idowu, BD; Gale, RE; Flanagan, AM; (2005) Differentiation between clear cell sarcoma and malignant melanoma using a molecular approach. In: JOURNAL OF PATHOLOGY. (pp. 5 - 5). JOHN WILEY & SONS LTD

Laurence, AD; Peggs, KS; (2005) Cerebral and pulmonary nocardia in a bone marrow transplant patient. Br J Haematol , 129 (6) 711 - ?. 10.1111/j.1365-2141.2005.05474.x.

Lawrence, T; Puel, A; Reichenbach, J; Ku, CL; Chapgier, A; Renner, E; ... Casanova, JL; + view all (2005) Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol , 12 (1) 22 - 30.

Ledermann, JA; Frickhofen, N; Wandt, H; Bengala, C; Champion, K; Hinke, A; ... EBMT AGO AIO,; + view all (2005) A phase III randomised trial of sequential high dose chemotherapy (HDC) with peripheral blood stem cell support or standard dose chemotherapy (SDC) for first-line treatment of ovarian cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 456S - 456S). AMER SOC CLINICAL ONCOLOGY

Lee, M; Sato, A; Kim, S; Scott, A; Ellington, M; Frazier, W; ... Kiakos, K; + view all (2005) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral seco-CBI analogs and CC-1065. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U344 - U344). AMER CHEMICAL SOC

LePla, RC; Landreau, CAS; Shipman, M; Hartley, JA; Jones, GDD; (2005) Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking. BIOORG MED CHEM LETT , 15 (11) 2861 - 2864. 10.1016/j.bcml.2005.03.091.

Lo, S; Tolner, B; Taanman, JW; Cooper, JM; Gu, M; Hartley, JA; ... Hochhauser, D; + view all (2005) Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents. INT J ONCOL , 27 (2) 337 - 344.

Lobo, VJSA; Luquero, CIA; Alvarez-Vallina, L; Tipping, AJ; Viniegra, JG; Losa, JH; ... Sanchez-Prieto, R; + view all (2005) Modulation of the p38 MAR (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C. BIOCHEM J , 387 231 - 238. 10.1042/BJ20040927.

Lomas, DA; (2005) Molecular mousetraps, alpha1-antitrypsin deficiency and the serpinopathies. Clin Med , 5 (3) 249 - 257.

Lomas, DA; (2005) The serpinopathies and dementia. In: CLINICA CHIMICA ACTA. (pp. S13 - S13).

Lomas, DA; Belorgey, D; Mallya, M; Miranda, E; Kinghorn, KJ; Sharp, LK; ... Crowther, DC; + view all (2005) Molecular mousetraps and the serpinopathies. BIOCHEMICAL SOCIETY TRANSACTIONS , 33 321 - 330.

Lomas, DA; Belorgey, D; Mallya, M; Miranda, E; Kinghorn, KJ; Sharp, LK; ... Crowther, DC; + view all (2005) Molecular mousetraps and the serpinopathies. Biochem Soc Trans , 33 (Pt 2) 321 - 330. 10.1042/BST0330321.


Mackinnon, S; (2005) Reduced intensity allogeneic stem cell transplantation for relapsed Hodgkin and non-Hodgkin lymphoma lowers regimen toxicity and facilitates a graft-versus-lymphoma effect. In: ANNALS OF ONCOLOGY. (pp. 34 - 34). OXFORD UNIV PRESS

Macrae, M; Neve, RM; Rodriguez-Viciana, P; Haqq, C; Yeh, J; Chen, CR; ... McCormick, F; + view all (2005) A conditional feedback loop regulates Ras activity through EphA2. CANCER CELL , 8 (2) 111 - 118. 10.1016/j.ccr.2005.07.005.

Mahadeva, R; Atkinson, C; Li, Z; Stewart, S; Janciauskiene, S; Kelley, DG; ... Lomas, DA; + view all (2005) Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol , 166 (2) 377 - 386.

Malone, FD; Canick, JA; Ball, RH; Nyberg, DA; Comstock, CH; Bukowski, R; ... FASTER Res Consortium,; + view all (2005) First-trimester or second-trimester screening, or both, for Down's syndrome. NEW ENGL J MED , 353 (19) 2001 - 2011. Green open access

Manoussaka, MS; Memon, A; Nathwani, A; Porakishvili, N; Clark, E; Lydyard, PM; (2005) Toll like receptors (TLRs) in B cell chronic lymphocytic leukemia (B-CLL). In: BLOOD. (pp. 326B - 326B). AMER SOC HEMATOLOGY

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2005) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukaemia. In: BLOOD. (pp. 417A - 418A). AMER SOC HEMATOLOGY

Mansouri, D; Adimi, P; Mirsaeidi, M; Mansouri, N; Khalilzadeh, S; Masjedi, MR; ... Casanova, JL; + view all (2005) Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr , 164 (12) 753 - 757. 10.1007/s00431-005-1689-9.

Marafioti, T; Pozzobon, M; Hansmann, ML; Gaulard, P; Barth, TF; Copie-Bergman, C; ... Mason, DY; + view all (2005) Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia , 19 (5) 856 - 861. 10.1038/sj.leu.2403702.

Marafioti, T; Pozzobon, M; Hansmann, ML; Ventura, R; Pileri, SA; Roberton, H; ... Mason, DY; + view all (2005) The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol , 128 (3) 333 - 342. 10.1111/j.1365-2141.2004.05313.x.

Marden, CM; North, J; Anderson, R; Bakhsh, IA; Addison, E; Pittman, H; ... Lowdell, MW; + view all (2005) CD69 is required for activated NK cell-mediated killing of resistant targets. In: BLOOD. (pp. 928A - 929A). AMER SOC HEMATOLOGY

Marie-Egyptienne, DT; Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2005) A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res , 33 (17) 5446 - 5457. 10.1093/nar/gki848.

Marks, AJ; Cooper, MS; Anderson, RJ; Orchard, KH; Hale, G; North, JM; ... Wickremasinghe, RG; + view all (2005) Selective apoptotic killing of malignant hemopoietic cells by anti body-targeted delivery of an amphipathic peptide. CANCER RES , 65 (6) 2373 - 2377.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Trowsdale, J; + view all (2005) Nomenclature for Factors of the HLA System, 2004. Human Immunology , 66 571 - 636.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. Tissue Antigens , 65 301 - 369.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. Human Immunology , 66 571 - 636.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. International Journal of Immunogenetics , 32 107 - 159.

Martin, C; Ellis, T; McGurk, CJ; Jenkins, TC; Hartley, JA; Waring, MJ; Thurston, DE; (2005) Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: Footprinting and enzyme inhibition studies. BIOCHEMISTRY-US , 44 (11) 4135 - 4147. 10.1021/bi0479813.

Mauri, P; Scarpa, A; Nascimbeni, AC; Benazzi, L; Parmagnani, E; Mafficini, A; ... Sorio, C; + view all (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J , 19 (7) 1125 - +. 10.1096/fj.04-3000fje.

Mawdsley, S; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; ... Wallace, M; + view all (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? International Journal of Radiation Oncology Biology Physics , 63 (3) 745 - 752.

Mayor, NP; Cox, ST; McWhinnie, AJ; Argüello, JR; Shaw, BE; Little, AM; ... Marsh, SG; + view all (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). Tissue Antigens , 65 (1) 107 - 109. 10.1111/j.1399-0039.2005.00340.x.

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, AM; ... Marsh, SGE; + view all (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 (1) 107 - 109. 10.1111/j.1399-0039.2004.00340.x.

McCarthy, K.; (2005) The influence and expression of IGFBP-3 in normal and malignant breast tissue. Doctoral thesis, University of London. Green open access

McMahon, K; Hadjur, S; Menzel, U; Kioussis, D; Brady, HJM; (2005) Elucidating the role of MLL in adult murine haematopoiesis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 10 - 10). BLACKWELL PUBLISHING

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2005) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. Pediatric Blood and Cancer , 46 (3) 345 - 350.

Meaburn, E; Butcher, LM; Liu, L; Fernandes, C; Hansen, V; Al-Chalabi, A; ... Schalkwyk, LC; + view all (2005) Genotyping DNA pools on microarrays: tackling the QTL problem of large samples and large numbers of SNPs. BMC Genomics , 6 , Article 52. 10.1186/1471-2164-6-52. Green open access

Mehta, A; Ginsberg, L; FOS Investigators,; (2005) Natural history of the cerebrovascular complications of Fabry disease. ACTA PAEDIATRICA , 94 24 - 27. 10.1080/08035320510028076.

Millar, CM; Starke, R; Riddell, AF; Griffioen, A; Mackie, I; Brown, SA; (2005) Investigation of relationship of von Willebrand factor antigen clearance with ADAMTS-13 activity and Tyr1584Cys polymorphism in type 1 von Willebrand disease. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 46 - 46). BLACKWELL PUBLISHING

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, S; (2005) Thrombotic thrombocytopaenic purpura in human immunodeficiency virus infected patients. International Journal of STD and AIDS , 16 538 - 542.

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, SJ; (2005) Thrombotic thrombocytopaenic purpura in HIV-infected patients. INT J STD AIDS , 16 (8) 538 - 542.

Mills, KI; Gilkes, AF; Walsh, V; Sweeney, M; Austin, SJ; Gale, RE; (2005) FLT3 gene mutations in AML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING

Miretti, MM; Walsh, EC; Ke, XY; Delgado, M; Griffiths, M; Hunt, S; ... Deloukas, P; + view all (2005) A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. AM J HUM GENET , 76 (4) 634 - 646.

Mittnacht, S; (2005) The retinoblastoma protein--from bench to bedside. Eur J Cell Biol , 84 (2-3) 97 - 107. 10.1016/j.ejcb.2004.12.012.

Moorman, AV; Harrison, CJ; Richards, SM; Fielding, A; Tallman, MS; Litzow, MR; ... Dewald, GW; + view all (2005) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial. In: BLOOD. (pp. 100A - 100A).

Mulholland, PJ; Thirlwell, C; Brock, CS; Newlands, ES; (2005) Emerging targeted treatments for malignant glioma. Expert Opin Emerg Drugs , 10 (4) 845 - 854. 10.1517/14728214.10.4.845.

Murphy, RT; Mogensen, J; McGarry, K; Bahl, A; Evans, A; Osman, E; ... McKenna, WJ; + view all (2005) Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome - Natural history. J AM COLL CARDIOL , 45 (6) 922 - 930. 10.1016/j.jacc.2004.11.053.

Murrell, A; Rakyan, VK; Beck, S; (2005) From genome to epigenome. HUM MOL GENET , 14 R3 - R10. 10.1093/hmg/ddi110.


Nacheva, E; Brazma, D; Foroni, L; Grace, C; (2005) A genome wide screening for genetic imbalances of CML by array CGH. In: EXPERIMENTAL HEMATOLOGY. (pp. 59 - 59).

Narat, S; Gandla, J; Dogan, A; Mehta, A; (2005) Successful treatment of hairy cell leukemia variant with rituximab. Leukemia and Lymphoma , 48 (8) 1229 - 1232.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. BRIT J HAEMATOL , 128 (1) 3 - 17. 10.1111/j.1365-2141.05231.x.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. Br J Haematol , 128 (1) 3 - 17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; Linch, DC; Davidoff, AM; (2005) A review of gene therapy for haematological disorders. British Journal of Haematology , 128 (1) 3 - 17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Current hematology reports. , 4 (4) 287 - 293.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Curr Hematol Rep , 4 (4) 287 - 293.

Natkunam, Y; Lossos, IS; Taidi, B; Zhao, S; Lu, X; Ding, F; ... Levy, R; + view all (2005) Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood , 105 (10) 3979 - 3986. 10.1182/blood-2004-08-3112.

Nebot, M; López, MJ; Gorini, G; Neuberger, M; Axelsson, S; Pilali, M; ... Centrich, FAHSK; + view all (2005) Environmental tobacco smoke exposure in public places of European cities. Tobacco Control , 14 60 - 63.

Nicholls, BM; Bredius, RGM; Hamdy, NAT; Gerritsen, EJA; Lankester, AC; Hogendoorn, PCW; ... Flanagan, AM; + view all (2005) Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. J BONE MINER RES , 20 (12) 2264 - 2270. 10.1359/JBMR.050807.

Norman, MW; Simpson, M; Mogensen, J; Shaw, A; Hughes, S; Sen-Chowdhry, S; ... McKenna, WJ; + view all (2005) A novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation , 112 (5) 636 - 642. Green open access


O'Brien, F; Sekhavat, M; Lowdell, M; (2005) Long-term storage of cryopreserved autologous bone marrow retains viable haematopoietic progenitor cells. In: BONE MARROW TRANSPLANTATION. (pp. S110 - S110).

O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2005) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) 233 - 239.

O'Shea, C; Klupsch, K; Choi, S; Bagus, B; Soria, C; Shen, J; ... Stokoe, D; + view all (2005) Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J , 24 (6) 1211 - 1221. 10.1038/sj.emboj.7600597.

Oakervee, HE; Popat, R; Curry, N; Smith, P; Morris, C; Drake, M; ... Cavenagh, JD; + view all (2005) PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. BRIT J HAEMATOL , 129 (6) 755 - 762. 10.1111/j.1365-2141.2005.05519.x.

Oberst, A; Rossi, M; Salomoni, P; Pandolfi, PP; Oren, M; Melino, G; Bernassola, F; (2005) Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun , 331 (3) 707 - 712. 10.1016/j.bbrc.2005.03.158.

Ohkura, N; Takahashi, M; Yaguchi, H; Nagamura, Y; Tsukada, T; (2005) Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner. J Biol Chem , 280 (32) 28927 - 28935. 10.1074/jbc.M502173200. Gold open access

Onda, M; Belorgey, D; Sharp, LK; Lomas, DA; (2005) Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies. J Biol Chem , 280 (14) 13735 - 13741. 10.1074/jbc.M413282200. Gold open access

Oses-Prieto, JA; Joubel, A; Rodriguez-Viciana, P; Fried, M; Burlingame, AL; (2005) Use of crosslinking and tandem affinity purification (TAP) methodology to identify new interaction partners of the kinase Mst-2. In: FASEB JOURNAL. (pp. A1397 - A1397). FEDERATION AMER SOC EXP BIOL


Padhani, AR; Ah-See, ML; Makris, A; (2005) MRI in the detection and management of breast cancer. Expert review of anticancer therapy , 5 (2) 239 - 252.

Palmieri, C; Davis, TN; Dhillon, T; Young, A; Powles, T; Thirlwell, C; ... Bower, M; + view all (2005) Pulmonary AIDS related Kaposi sarcoma in the era of HAART. EJC SUPPL , 3 (2) 380 - 380.

Parker, LL; Anderson, FM; O'Hare, CC; Lacy, SM; Bingham, JP; Robins, DJ; Hartley, JA; (2005) Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. BIOORGAN MED CHEM , 13 (7) 2389 - 2395. 10.1016/j.bmc.2005.01.055.

Pascolo, S; Ginhoux, F; Laham, N; Walter, S; Schoor, O; Probst, J; ... Rammensee, HG; + view all (2005) The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells. Int Immunol , 17 (2) 117 - 122. 10.1093/intimm/dxh191.

Patel, B; Goldstone, AH; Ross, P; Richards, S; Foroni, L; Chopra, R; Fielding, A; (2005) The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study. In: BLOOD. (pp. 523A - 523A).

Peggs, KS; (2005) The role of alemtuzumab in allogeneic stem cell transplantation. In: Hillmen, P and Witzig, TE, (eds.) Therapeutic Strategies in Lymphoid Malignancy. (177 - 188). Informa HealthCare

Peggs, KS; Allison, JP; (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. BRIT J HAEMATOL , 130 (6) 809 - 824.

Peggs, KS; Mackinnon, S; Linch, DC; (2005) The role of allogeneic transplantation in non-Hodgkin's lymphoma. BRIT J HAEMATOL , 128 (2) 153 - 168. 10.1111/j.1365-2141.2004.05251.x.

Peggs, KS; Thomson, KJ; Morris, EC; Goldstone, AH; Linch, DC; MacKinnon, S; ... Waldmann, H; + view all (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet , 365 (9475) 1934 - 1941. 10.1016/S0140-6736(05)66659-7.

Peleg, M; Steele, R; Thomson, R; Patkar, V; Rose, T; Fox, J; (2005) Open-source publishing of medical knowledge for creation of computer-interpretable guidelines. In: Miksch, S and Hunter, J and Keravnou, E, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 156 - 160). SPRINGER-VERLAG BERLIN

Peltenburg, LT; de Bruin, EC; Meersma, D; Smit, NP; Schrier, PI; Medema, JP; (2005) Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ , 12 (6) 678 - 679. 10.1038/sj.cdd.4401630.

Pennell, DJ; Anderson, LJ; Paul, K; Forni, GL; Ellis, G; Walker, JM; Porter, JB; (2005) Calibration of myocardial T2*values in post-mortem hearts. In: BLOOD. (pp. 40B - 40B). AMER SOC HEMATOLOGY

Peter, M; Ameer-Beg, SM; Hughes, MK; Keppler, MD; Prag, S; Marsh, M; ... Ng, T; + view all (2005) Multiphoton-FLIM quantification of the EGFP-mRFP1 FRET pair for localization of membrane receptor-kinase interactions. Biophys J , 88 (2) 1224 - 1237. 10.1529/biophysj.104.050153.

Pillay, OC; Wong Te Fong, LF; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; ... Hardiman, P; + view all (2005) The association between polycystic ovaries and endometrial cancer. Human Reproduction

Pina, C; Enver, T; (2005) Transcriptional programming in quiescent human hematopoietic stem cells - Implications for regulation of lineage commitment decisions. In: BLOOD. (pp. 491A - 491A). AMER SOC HEMATOLOGY

Pina, C; Pinto, F; Feijó, JA; Becker, JD; (2005) Gene family analysis of the Arabidopsis pollen transcriptome reveals biological implications for cell growth, division control, and gene expression regulation. Plant Physiol , 138 (2) 744 - 756. 10.1104/pp.104.057935.

Pinheiro, P; Ciau-Uitz, A; Patient, R; Enver, T; (2005) ETV6/TEL1 is required for HSC embryonic development. In: BLOOD. (pp. 1005A - 1005A). AMER SOC HEMATOLOGY

Pinto, ES; Mensah, R; Meeran, K; Cameron, JD; Murugaesu, N; Bulpitt, CJ; Rajkumar, C; (2005) Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. Diabetes Care , 28 (2) 496 - ?.

Plummer, ER; Middleton, MR; Jones, C; Olsen, A; Hickson, I; McHugh, P; ... Curtin, NJ; + view all (2005) Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. CLIN CANCER RES , 11 (9) 3402 - 3409.

Plummer, R; Middleton, M; Wilson, R; Evans, J; Jones, C; Olson, A; ... Calvert, H; + view all (2005) Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide. In: CLINICAL CANCER RESEARCH. (pp. 9099S - 9099S). AMER ASSOC CANCER RESEARCH

Plummer, R; Middleton, M; Wilson, R; Jones, C; Evans, J; Robson, L; ... Calvert, AH; + view all (2005) First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY , 23 (16) 208S - 208S.

Plummer, R; Vidal, L; Perrett, R; Shaw, H; Pilkington, M; Hanwell, J; ... de Bono, J; + view all (2005) A phase 1 dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a continuous schedule in patients with advanced solid tumors. In: CLINICAL CANCER RESEARCH. (pp. 8990S - 8990S). AMER ASSOC CANCER RESEARCH

Pool-Zobel, B; Veeriah, S; Böhmer, FD; (2005) Modulation of xenobiotic metabolising enzymes by anticarcinogens -- focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res , 591 (1-2) 74 - 92. 10.1016/j.mrfmmm.2005.04.020.

Popat, R; Goff, L; Oaekervee, HE; Cavenagh, JD; Joel, SP; (2005) Changes in Mcl-1 and Bim expression with bortezomib and melphalan therapy for multiple myeloma. In: BLOOD. (pp. 697A - 697A). AMER SOC HEMATOLOGY

Popat, R; Oakervee, H; Foot, N; Curry, N; Morris, C; Drake, M; ... Cavenagh, JD; + view all (2005) PAD (PS-341/bortezomib, adriamycin and dexamethasone) as front-line therapy for untreated patients with multiple myeloma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 22 - 22). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Agrawal, S; Smith, P; Singer, C; Craddock, C; ... Cavenagh, JD; + view all (2005) A phase I/II trial of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 27 - 27). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Curry, N; Foot, N; Morris, C; Drake, M; ... Cavenagh, JD; + view all (2005) Reduced dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: BLOOD. (pp. 717A - 718A). AMER SOC HEMATOLOGY

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Smith, P; Craddock, C; ... Cavenagh, JD; + view all (2005) A phase I/II study of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: BLOOD. (pp. 718A - 718A). AMER SOC HEMATOLOGY

Pors, K; Phillips, RM; Hartley, JA; Patterson, LH; (2005) N-oxides of alkylating anthraquinones as hypoxia-targeting prodrugs. In: CLINICAL CANCER RESEARCH. (pp. 9053S - 9053S). AMER ASSOC CANCER RESEARCH

Porter, JB; (2005) Liver iron measurement by MRI. BLOOD , 105 (2) 437 - 438.

Porter, JB; (2005) Monitoring and treatment of iron overload: State of the art and new approaches. SEMIN HEMATOL , 42 (2) S14 - S18. 10.1053/j.seminhematol.2005.01.004.

Porter, JB; Rafique, R; Srichairatanakool, S; Davis, BA; Shah, FT; Hair, T; Evans, P; (2005) Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use. COOLEY'S ANEMIA EIGHTH SYMPOSIUM , 1054 155 - 168. 10.1196/annals.1345.018.

Porter, JB; Tanner, MA; Pennell, DJ; Eleftheriou, P; (2005) Improved myocardial T2*in transfusion dependent anemias receiving ICL670 (Deferasirox). In: BLOOD. (pp. 1003A - 1003A). AMER SOC HEMATOLOGY

Presneau, N; Dewar, K; Forgetta, V; Provencher, D; Mes-Masson, AM; Tonin, PN; (2005) Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2. MOL CARCINOGEN , 43 (3) 141 - 154. 10.1002/mc.20096.

Presneau, N; Shen, Z; Provencher, D; Mes-Masson, AM; Tonin, PN; (2005) Identification of novel variant, 1484delG in the 3 ' UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors. INT J ONCOL , 26 (6) 1621 - 1627.

Preston, S; McDonald, S; Oukrif, D; Greaves, L; Turnbull, D; Tadrous, P; ... Wright, N; + view all (2005) Clusters of phenotypically related human colonic crypts develop through crypt fission: Implications for colorectal carcinogenesis. In: GASTROENTEROLOGY. (pp. A493 - A493). W B SAUNDERS CO

Preston, SL; McDonald, SAC; Oukrif, D; Greaves, L; Turnbull, D; Tadrous, P; ... Wright, NA; + view all (2005) Clusters of phenotypically related human colonic crypts develop through crypt fission: Implications for colorectal carcinogenesis. In: GUT. (pp. A24 - A24). B M J PUBLISHING GROUP

Price, CA; Lingerfelt, BM; Handl, HL; Kiakos, K; Hartley, JA; Lee, M; (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. BIOORG MED CHEM LETT , 15 (12) 3151 - 3156. 10.1016/j.bmcl.2005.04.006.

Pritchard-Jones, K; Spendlove, I; Wilton, C; Durrant, LG; Whelan, J; Weeden, S; ... Halbert, G; + view all (2005) Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. British Journal of Cancer , 92 (8) 1358 - 1365. 10.1038/sj.bjc.6602500.

Pulè, MA; Straathof, KC; Dotti, G; Heslop, HE; Rooney, CM; Brenner, MK; (2005) A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Molecular Therapy , 12 (5) 933 - 941. 10.1016/j.ymthe.2005.04.016.

Puleston, J; Cooper, M; Murch, S; Bid, K; Makh, S; Ashwood, P; ... Platt, A; + view all (2005) A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther , 21 (2) 109 - 120. 10.1111/j.1365-2036.2004.02262.x.


Quaglia, A; Etessami, N; Sim, R; Difford, J; Dhillon, AP; (2005) Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis - A wolf in sheep's clothing? ARCH PATHOL LAB MED , 129 (5) 639 - 644.

Quaglia, A; Jutand, MA; Dhillon, A; Godfrey, A; Togni, R; Bioulac-Sage, P; ... Dhillon, AP; + view all (2005) Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. World J Gastroenterol , 11 (40) 6262 - 6268. Gold open access

Quezada, SA; Bennett, K; Blazar, BR; Rudensky, AY; Sakaguchi, S; Noelle, RJ; (2005) Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: The interplay of clonal anergy and immune regulation. J IMMUNOL , 175 (2) 771 - 779.


Rada-Iglesias, A; Wallerman, O; Koch, C; Ameur, A; Enroth, S; Clelland, G; ... Wadelius, C; + view all (2005) Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. HUM MOL GENET , 14 (22) 3435 - 3447. 10.1093/hmg/ddi378.

Rades, D; Stalpers, LJA; Veninga, T; Hoskin, PJ; (2005) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) 872 - 875.

Raghavan, M; Gale, RE; Skoulakis, S; Chaplin, T; Molloy, GY; Linch, DC; ... Young, BD; + view all (2005) An increased frequency of abnormalities including uniparental disomy is detected by SNP array compared with conventional karyotype analysis in acute myeloid leukemia. In: BLOOD. (pp. 33A - 33A). AMER SOC HEMATOLOGY

Raja, FA; Bridgewater, JA; (2005) Survival following first line fluorouracil single agent therapy for advanced colarectal cancer in a cancer unit practice in the United Kingdom (UK). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 274S - 274S). AMER SOC CLINICAL ONCOLOGY

Reid, AG; Nacheva, EP; (2005) Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia. GENE CHROMOSOME CANC , 43 (2) 223 - 224. 10.1002/gcc.20163.

Renzulli, M; Grafone, T; Taccioli, C; Terragna, C; Boschelli, F; Mancini, M; ... Martinelli, G; + view all (2005) Gene expression profile in the CML cell line K562 treated with SKI-606, a dual inhibitor of Src/Abl kinase. In: BLOOD. (pp. 297B - 298B). AMER SOC HEMATOLOGY

Robertson, JFR; Come, SE; Jones, SE; Beex, L; Kaufmann, M; Makris, A; ... Rutqvist, LE; + view all (2005) Endocrine treatment options for advanced breast cancer - the role of fulvestrant. EUROPEAN JOURNAL OF CANCER , 41 (3) 346 - 356.

Robinson, J; Waller, MJ; Stoehr, P; Marsh, SGEP15608253PIFMEDLINE; (2005) IPD--the Immuno Polymorphism Database. Nucleic Acids Research , 33 523 - 526. 10.1093/nar/gki032. Gold open access

Rodriguez, T; Mendez, R; Roberts, CH; Ruiz-Cabello, F; Dodi, IA; Lopez Nevot, MA; ... Garrido, F; + view all (2005) High frequency of homozygosity of the HLA region in Melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. Cancer Immunology, Immunotherapy , 54 141 - 148.

Rodriguez-Viciana, P; McCormick, F; (2005) RaIGDS comes of age. CANCER CELL , 7 (3) 205 - 206.

Rodriguez-Viciana, P; Tetsu, O; Oda, K; Okada, J; Rauen, K; McCormick, F; (2005) Cancer targets in the Ras pathway. Molecular Approaches to Controlling Cancer , 70 461 - 467.

Rogers, SL; Gobel, TW; Viertlboeck, BC; Milne, S; Beck, S; Kaufman, J; (2005) Characterization of the chicken C-type lectin-like receptors B-NK and B-lec suggests that the NK complex and the MHC share a common ancestral region. J IMMUNOL , 174 (6) 3475 - 3483.

Rooney, CM; Straathof, KC; Pulè, MA; Yotnda, P; Dotti, G; Vanin, EF; ... Spencer, DM; + view all (2005) An inducible caspase 9 safety switch for T-cell therapy. Blood , 105 (11) 4247 - 4254. 10.1182/blood-2004-11-4564. Green open access

Rubio, MT; Means, TK; Chakraverty, R; Shaffer, J; Fudaba, Y; Chittenden, M; ... Sykes, M; + view all (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E-2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE(2) in chemokine and cytokine expression by MoDCs. INT IMMUNOL , 17 (12) 1561 - 1572. 10.1093/intimm/dxh335.

Rudd, RM; Gower, NH; Spiro, SG; Eisen, TG; Harper, PG; Littler, JAH; ... Lee, SM; + view all (2005) Gemcitabine plus Carboplatin versus Mitomycin,Ifosfamide, and Cisplatin in patients with stage IIIB orIV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) 142 - 153. 10.1200/JCO.2005.03.037.


Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA; (2005) Twenty five years of HIV infection in haemophilic men in Britain: an observational study. BRIT MED J , 331 (7523) 997 - 998. 10.1136/bmj.38604.468785.DE. Gold open access

Salomoni, P; Bernardi, R; Bergmann, S; Changou, A; Tuttle, S; Pandolfi, PP; (2005) The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. BLOOD , 105 (9) 3686 - 3690. 10.1182/blood-2004-09-3782.

Salomoni, P; Dyer, MJS; (2005) Delta N-p73: the enemy within. CELL DEATH DIFFER , 12 (12) 1553 - 1554. 10.1038/sj.cdd.4401802.

Sambrook, JG; Bashirova, A; Palmer, S; Sims, S; Trowsdale, J; Abi-Rached, L; ... Beck, S; + view all (2005) Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. GENOME RES , 15 (1) 25 - 35. 10.1101/gr.2381205.

Sambrook, JG; Figueroa, F; Beck, S; (2005) A genome-wide survey of Major Histocompatibility Complex (MHC) genes and their paralogues in zebrafish. BMC GENOMICS , 6 , Article 152. 10.1186/1471-2164-6-152. Green open access

Samuel, E; Sekhavat, M; O'Brien, F; Pang, K; Ankrah, J; Mackinnon, S; Lowdell, M; (2005) Effect of conditioning regimen on the relationship between CD34 cell dose and time to engraftment after allogeneic stem cell transplant. In: BONE MARROW TRANSPLANTATION. (pp. S109 - S109). NATURE PUBLISHING GROUP

Sato, A; McNulty, LA; Cox, K; Kim, S; Scott, A; Daniell, K; ... Lee, M; + view all (2005) A novel class of in vivo active anticancer agents: Achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J MED CHEM , 48 (11) 3903 - 3918. 10.1021/jm050179u.

Sánchez-Sánchez, F; Kruetzfeldt, M; Nájera, C; Mittnacht, S; (2005) A novel constitutional mutation affecting splicing of retinoblastoma tumor suppressor gene intron 23 causes partial loss of pRB activity. Hum Mutat , 25 (2) 223 - ?. 10.1002/humu.9305.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; ... M,; + view all (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Human Immunology , 66 170 - 210.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; ... M,; + view all (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. International Journal of Immunogenetics , 32 19 - 69.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; ... M,; + view all (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 65 1 - 55.

Schuh, AH; Tipping, AJ; Clark, AJ; Hamlett, I; Guyot, B; Iborra, FJ; ... Porcher, C; + view all (2005) ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. MOL CELL BIOL , 25 (23) 10235 - 10250. 10.1128/MCB.25.23.10235-10250.2005.

Scully, M; Cavenagh, J; Hagger, D; Benjamin, S; Mackie, I; Mchin, SJ; Cohen, H; (2005) Normalisation of ADAMTS 13 activity and disappearance of ADAMTS 13 antibody following rituximab in acute refractory thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 357A - 358A). AMER SOC HEMATOLOGY

Scully, M; Miller, R; Cohen, H; Roedling, S; Edwards, S; Machin, SJ; (2005) Management of HIV associated thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 845A - 845A). AMER SOC HEMATOLOGY

Scully, M; Miller, R; Cohen, H; Roedling, S; Starke, R; Edwards, S; ... Machin, S; + view all (2005) Treatment of HIV associated thrombotic thrombocytopenic purpura - importance of prompt diagnosis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 12 - 12). BLACKWELL PUBLISHING

Scully, M; Starke, R; Flynn, M; Haggar, D; Mackie, I; Machin, S; Cohen, H; (2005) Use of Rituximab in acute refractory thrombotic thrombocytopenic purpura. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, SJ; Cohen, H; (2005) Successful pregnancy outcome in 5 patients with thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 845A - 845A). AMER SOC HEMATOLOGY

Seddon, BM; Cassoni, AM; Galloway, MJ; Rees, JH; Whelan, JS; (2005) Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice. CLIN ONCOL-UK , 17 (5) 385 - 390. 10.1016/j.clon.2005.03.004.

Seddon, BM; McTiernan, AM; Michelagnoli, MP; Gabbie, S; Daw, S; Whelan, JS; (2005) High-dose ifosfamide in relapsed or progressive Ewing's sarcoma. In: Sarcoma Meeting Stuttgart, June, 2005. Sarcoma 2005; 9(1/2): 108 (P150).

Seldon, PM; Meja, KK; Giembycz, MA; (2005) Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase. Pulm Pharmacol Ther , 18 (4) 277 - 284. 10.1016/j.pupt.2004.12.012.

Senis, YA; Atkinson, BT; Pearce, AC; Wonerow, P; Auger, JM; Okkenhaug, K; ... Watson, SP; + view all (2005) Role of the p110 delta PI 3-kinase in integrin and ITAM receptor signalling in platelets. PLATELETS , 16 (3-4) 191 - 202. 10.1080/09537100400016711.

Shah, JS; Hughes, D; Tayebjee, MH; MacFadyen, R; Mehta, A; Elliott, PM; (2005) Extracellular matrix turnover in patients with Anderson-Fabry disease. In: EUROPEAN HEART JOURNAL. (pp. 398 - 398). OXFORD UNIV PRESS

Shah, JS; Hughes, DA; Sachdev, B; Tome, M; Ward, D; Lee, P; ... Elliott, PA; + view all (2005) Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. AM J CARDIOL , 96 (6) 842 - 846. 10.1016/j.amjcard.2005.05.033.

Shah, JS; Lee, P; Hughes, D; Thaman, R; Sachdev, B; Pellerin, D; ... Elliott, PM; + view all (2005) The natural history of left ventricular systolic function in Anderson-Fabry disease. HEART , 91 (4) 533 - 534. 10.1136/hrt.2004.035584.

Shah, JS; Tayabjee, MH; Hughes, D; Mehta, A; McFadyen, R; Elliott, PM; (2005) Disease severity and abnormal collagen turn over in Anderson Fabry disease (AFD). In: HEART. (pp. A70 - A70). B M J PUBLISHING GROUP

Sharma, SK; Bagshawe, KD; Begent, RH; (2005) Advances in antibody-directed enzyme prodrug therapy. Curr Opin Investig Drugs , 6 (6) 611 - 615.

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; El-Emir, E; Qureshi, U; ... Chester, KA; + view all (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. CLIN CANCER RES , 11 (2) 814 - 825.

Shaw, BE; Barber, LD; Mayor, NP; Marsh, SGE; Madrigal, JA; (2005) HLA-DPB1 specific responses between unrelated individuals can be demonstrated by the production of interferon gamma in an ELISpot assay. In: BONE MARROW TRANSPLANTATION. (pp. S140 - S141). NATURE PUBLISHING GROUP

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2005) Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced intensity transplants reduces the relapse risk and results in significantly improved survival compared to those with persistent full donor chimerism. In: BLOOD. (pp. 573A - 573A). AMER SOC HEMATOLOGY

Shaw, BE; Gilyead, M; Das-Gupta, E; Byrne, JL; (2005) The use of HLA mismatched, bone marrow derived haematopoietic stem cells is significantly associated with primary non-engraftment in recipients of reduced-intensity conditioned transplants from unrelated donors. In: BONE MARROW TRANSPLANTATION. (pp. S202 - S202). NATURE PUBLISHING GROUP

Shaw, BE; Gilyead, M; Das-Gupta, E; Madrigal, JA; Byrne, JL; Russell, NH; (2005) Donor factors are significantly associated with primary non-engraftment in recipients of reduced intensity conditioned (RIC) transplants from unrelated donors. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 41 - 41). BLACKWELL PUBLISHING

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, A; (2005) Particular HLA-DPB1 allele mismatches predict for worse overall survival in recipients of unrelated donor haematopoietic stem cell transplants. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 13 - 13). CARDEN JENNINGS PUBL CO LTD

Shaw, BE; Russell, NH; Devereux, S; Das-Gupta, E; MacKinnon, S; Madrigal, JA; ... Byrne, JL; + view all (2005) The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. HAEMATOL-HEMATOL J , 90 (11) 1562 - 1569. Gold open access

Shaw, BE; Russell, NH; Devereux, S; Emma, DG; Stephen, M; Madrigal, JA; ... Byrne, JL; + view all (2005) Single HLA allele mismatches are well tolerated in the recipients of T cell depleted reduced intensity conditioned transplants from unrelated donors. In: BLOOD. (pp. 812A - 812A). AMER SOC HEMATOLOGY

Short, S; Bourne, S; Martindale, C; Woodcock, M; Jackson, SP; (2005) DNA damage responses at low radiation doses. Radiation Research , 164 (3) 292 - 302. 10.1667/RR3421.1.

Sieben, NLG; Oosting, J; Flanagan, AM; Prat, J; Roemen, GMJM; Kolkman-Uljee, SM; ... van Engeland, M; + view all (2005) Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J CLIN ONCOL , 23 (29) 7257 - 7264. 10.1200/JCO.2005.02.2541.

Simon, M; Grandage, VL; Linch, DC; Khwaja, A; (2005) Constitutive activation of the Wnt/ss-catenin signalling pathway in acute myeloid leukaemia. ONCOGENE , 24 (14) 2410 - 2420. 10.1038/sj.onc.1208431.

Simpson, CL; Knight, J; Butcher, LM; Hansen, VK; Meaburn, E; Schalkwyk, LC; ... Al-Chalabi, A; + view all (2005) A central resource for accurate allele frequency estimation from pooled DNA genotyped on DNA microarrays. Nucleic Acids Res. , 33 (3) e25 - ?. 10.1093/nar/gni028.

Smith, A; Wisloff, F; Samson, DOBOTUKMF; Nordic, MSGABCFSIH; (2005) Guidelines on the diagnosis and management of multiple myeloma. British Journal of Haematology , 132 410 - 451.

Song, L; Zlobin, A; Ghoshal, P; Zhang, Q; Houde, C; Weijzen, S; ... Coignet, LJ; + view all (2005) Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. Cancer Res , 65 (11) 4554 - 4561. 10.1158/0008-5472.CAN-04-4108.

Stainsby, D; Russell, J; Cohen, H; Lilleyman, J; (2005) Reducing adverse events in blood transfusion. British journal of haematology , 131 8 - 12.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; ... Machin, S; + view all (2005) The expression of prion protein (PrPc) in the megakaryocyte lineage. J THROMB HAEMOST , 3 (6) 1266 - 1273.

Starke, R; Mackie, I; Purdy, G; Scully, M; Machin, S; (2005) The sensitive detection of antibodies to von Willebrand factor cleaving protease (ADAMTS-13). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 17 - 17). BLACKWELL PUBLISHING

Stebbing, J; Mandalia, S; Young, AM; Dhillon, T; Newshom-Davis, T; Thirlwell, C; ... Bower, M; + view all (2005) A new prognostic index for systemic AIDS-related lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 844S - 844S). AMER SOC CLINICAL ONCOLOGY

Stegert, MR; Hergovich, A; Tamaskovic, R; Bichsel, SJ; Hemmings, BA; (2005) Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3. MOL CELL BIOL , 25 (24) 11019 - 11029. 10.1128/MCB.25.24.11019-11029.2005.

Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; ... Wooster, R; + view all (2005) A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. NAT GENET , 37 (6) 590 - 592. 10.1038/ng1571.

Steward, CG; Blair, A; Moppett, J; Clarke, E; Virgo, P; Lankester, A; ... Orchard, PJ; + view all (2005) High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis. BIOL BLOOD MARROW TR , 11 (2) 115 - 121. 10.1016/j.bbmt.2004.11.001.

Streck, CJ; Dickson, PV; Catherine, YIG; Zhou, JF; Gray, JT; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models. CLIN CANCER RES , 11 (16) 6020 - 6029. 10.1158/1078-0432.CCR-05-0502.

Streck, CJ; Ng, CYC; Zhang, YB; Zhou, JF; Nathwani, AC; Davidoff, AM; (2005) Interferon-mediated anti-angiogenic therapy for neuroblastoma. CANCER LETT , 228 (1-2) 163 - 170. 10.1016/j.canlet.2004.11.063.

Streck, CJ; Zhang, YB; Zhou, JF; Ng, C; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. JOURNAL OF PEDIATRIC SURGERY , 40 (1) 236 - 243. 10.1016/j.jpedsurg.2004.09.049.

Stuart-Smith, SE; Hughes, DA; Bain, BJ; (2005) Are routine iron stains on bone marrow trephine biopsy specimens necessary? Journal of Clinical Pathology , 58 269 - 272.

Sujobert, P; Bardet, V; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; Verdier, F; ... Bouscary, D; + view all (2005) Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood , 106 (3) 1063 - 1066. 10.1182/blood-2004-08-3225.


Taher, A; Sheikh-Taha, M; Sharara, A; Inati, A; Koussa, S; Ellis, G; ... Hoffbrand, AV; + view all (2005) Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: A two-year study. ACTA HAEMATOL-BASEL , 114 (3) 146 - 149. 10.1159/000087888.

Taherbhai, Z; Bailey, S; Sutterfield, A; Buchmueller, K; Nguyen, B; Kotecha, M; ... Lee, M; + view all (2005) ZT-65B, a hairpin polyamide that binds to the inverted CCAAT box (ICB) site of the human multidrug resistant (MDR1) gene: Design, DNA binding, and biological studies. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U542 - U543). AMER CHEMICAL SOC

Tan, SV; Lee, PJ; Walters, RJL; Mehta, A; Bostock, H; (2005) Evidence for motor axon depolarization in Fabry disease. MUSCLE & NERVE , 32 (4) 548 - 551. 10.1002/mus.20390.

Tanner, MA; Porter, JB; Westwood, MA; Nair, SV; Anderson, LJ; Walker, JM; Pennell, DJ; (2005) Myocardial T2*in patients with cardiac failure secondary to iron overload. In: BLOOD. (pp. 40B - 40B). AMER SOC HEMATOLOGY

Tauro, S; Craddock, C; Peggs, K; Begum, G; Mahendra, P; Cook, G; ... Mackinnon, S; + view all (2005) Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. J CLIN ONCOL , 23 (36) 9387 - 9393. 10.1200/JCO.2005.02.0057.

Tauro, S; Mackinnon, S; Peggs, K; Begum, G; Mahendra, P; Cook, G; ... Craddock, C; + view all (2005) Allogeneic stem cell transplantation using a reduced intensity conditioning (RIC) regimen has the capacity to produce durable remissions and long term disease-free survival in patients with high risk acute myeloid leukemia (AML). In: BLOOD. (pp. 332A - 332A). AMER SOC HEMATOLOGY

Thomas, MJ; Smith, A; Head, DH; Milne, L; Nicholls, A; Pearce, W; ... Westwick, J; + view all (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. EUR J IMMUNOL , 35 (4) 1283 - 1291. 10.1002/eji.200425634.

Thomson, A; Mayne, N; Bamford, A; Daw, S; Whelan, J; Michelagnoli, M; (2005) Acute anthracycline-induced cardiotoxicity in children and adolescents treated for bone cancer. In: SIOP XXXVI Meeting, Vancouver, Canada, Nov 2005.

Thomson, KJ; Hart, DP; Banerjee, L; Ward, KN; Peggs, KS; Mackinnon, S; (2005) The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. BONE MARROW TRANSPL , 35 (11) 1065 - 1069. 10.1038/sj.bmt.1704959.

Thomson, KJ; Morris, EC; Milligan, D; Cook, G; Cavet, J; Craddock, C; ... Mackinnon, S; + view all (2005) Reduced intensity allogeneic transplantation for non-Hodgkin's Lymphoma: Extended follow-up of an alemtuzumab-containing regimen. In: BLOOD. (pp. 120A - 121A). AMER SOC HEMATOLOGY

Thomson, KJ; Peggs, KS; (2005) Role of allogeneic stem cell transplantation in multiple myeloma. EXPERT REV ANTICANC , 5 (3) 455 - 464. 10.1586/14737140.5.3.455.

Thomson, KJ; Peggs, KS; Smith, P; Chopra, R; Cavet, J; Hunter, A; ... Mackinnon, S; + view all (2005) Improved outcome following reduced intensity allogeneic transplantation in Hodgkin's lymphoma relapsing post-autologous transplantation. In: BLOOD. (pp. 194A - 194A). AMER SOC HEMATOLOGY

Thomson, KJ; Peggs, KS; Sureda, A; Hunter, A; Caballero, MD; Cavet, J; ... Mackinnon, S; + view all (2005) Impact of in vivo T cell depletion on outcome following reduced intensity transplantation with matched related donors for Hodgkin lymphoma: comparison between two prospective studies. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 34 - 34). BLACKWELL PUBLISHING

Tiwana, H; Clow, KJ; Hall, C; Feavers, IM; Charalambous, BM; (2005) The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide. SCAND J IMMUNOL , 62 (4) 385 - 392. 10.1111/j.1365-3083.2005.01671.x.

Toth, JL; Trzupek, JD; Flores, LV; Kiakos, K; Hartley, JA; Pennington, WT; Lee, M; (2005) A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies. Med Chem , 1 (1) 13 - 19.

Tsuzuki, S; Hong, DL; Eguchi, M; Eguchi, M; Greaves, M; Brown, J; ... Enver, T; + view all (2005) Developmental impact of leukaemia associated fusion genes on stem cell fate. In: BLOOD CELLS MOLECULES AND DISEASES. (pp. 85 - 85). ACADEMIC PRESS INC ELSEVIER SCIENCE


van Duin, M; van Marion, R; Watson, JEV; Paris, PL; Lapuk, A; Brown, N; ... Collins, C; + view all (2005) Construction and application of a full-coverage high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. In: CYTOM PART A. (pp. 10 - 19). WILEY-LISS

Vanhaesebroeck, B; Ali, K; Bilancio, A; Geering, B; Foukas, LC; (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci , 30 (4) 194 - 204. 10.1016/j.tibs.2005.02.008.

Vaquerizas, JM; Conde, L; Yankilevich, P; Cabezón, A; Minguez, P; Díaz-Uriarte, R; ... Dopazo, J; + view all (2005) GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res , 33 (Web Server issue) W616 - W620. 10.1093/nar/gki500.

UNSPECIFIED (Ed). (2005) Novel implantable delivery system increases maximum tolerable doses of paclitaxel in mice. [Whole issue]. Proc Amer Assoc Cancer Res , 46

Venables, K; Miles, EA; Hoskin, PJ; Aird, EGA; (2005) Verification films: A study of the daily and weekly reproducibility of breast patient set-up in the START trial. Clinical Oncology , 17 (5) 337 - 342.

Verfuerth, S; Pizzey, AR; Chow, SLC; Chowdhry, N; Mackinnon, S; (2005) In vitro expansion of CMV-specific T cells from CMV seronegative donors. In: BLOOD. (pp. 62B - 62B). AMER SOC HEMATOLOGY

Vichinsky, E; Fischer, R; Fung, E; Onyekwere, O; Porter, J; Swerdlow, P; ... Marks, P; + view all (2005) A randomized, controlled phase II trial in sickle cell disease patients with chronic iron overload demonstrates that the once-daily oral iron chelator deferasirox (Exjade((R)) ICL670) is well tolerated and reduces iron burden. In: BLOOD. (pp. 95A - 95A). AMER SOC HEMATOLOGY

Vichinsky, E; Fischer, R; Pakbaz, Z; Onyekwere, O; Porter, J; Swerdlow, P; ... Marks, P; + view all (2005) Satisfaction and convenience of chelation therapy in patients with sickle cell disease (SCD): Comparison between deferasirox (Exjade((R)), ICL670) and deferoxamine (DFO). In: BLOOD. (pp. 656A - 657A). AMER SOC HEMATOLOGY

Vidal, L; Leslie, M; Sludden, J; Griffin, MG; Plummer, R; Judson, I; ... Boddy, AV; + view all (2005) A phase I and pharmacodynamic study of a 7 day infusion schedule of the DNMT1 antisense compound MG98. JOURNAL OF CLINICAL ONCOLOGY , 23 (16) 209S - 209S.

Viviani, B; Bartesaghi, S; Corsini, E; Villa, P; Ghezzi, P; Garau, A; ... Marinovich, M; + view all (2005) Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J NEUROCHEM , 93 (2) 412 - 421. 10.1111/j.1471-4159.2005.03033.x.

Vogt, G; Chapgier, A; Yang, K; Chuzhanova, N; Feinberg, J; Fieschi, C; ... Casanova, JL; + view all (2005) Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet , 37 (7) 692 - 700. 10.1038/ng1581.


Wald, NJ; Rodeck, C; Hackshaw, AK; Rudnicka, A; (2005) SURUSS in perspective. SEMINARS IN PERINATOLOGY , 29 (4) 225 - 235. 10.1053/j.semperi.2005.05.006.

Wald, NJ; Rodeck, C; Hackshaw, AK; Rudnicka, A; (2005) The future of antenatal screening for Down's Syndrome - Reply. BJOG-INT J OBSTET GY , 112 (1) ? - ?. 10.1111/j.1471-0528.2005.00475.x.

Walker, BA; van Hateren, A; Milne, S; Beck, S; Kaufman, J; (2005) Chicken TAP genes differ from their human orthologues in locus organisation, size, sequence features and polymorphism. IMMUNOGENETICS , 57 (3-4) 232 - 247. 10.1007/s00251-005-0786-2.

Walter, P; Macklin, E; Porter, J; Evans, P; Coates, T; Olivieri, NF; ... Harmatz, P; + view all (2005) Control of oxidant-stress and inflammation by iron chelators deferasirox (ICL670) or deferoxamine in beta-thalassemia: An ancillary study of the novartis CICL670A0107 trial. In: BLOOD. (pp. 1003A - 1003A). AMER SOC HEMATOLOGY

Walton, J; Lawson, K; Manoussaka, MS; Nathwani, A; Emory, V; Lydyard, PM; Porakishvili, N; (2005) CD4(+) perforin(+) T cells in B-CLL: MHC class II restriction and anti-cytomegalovirus reactivity. In: BLOOD. (pp. 325B - 326B). AMER SOC HEMATOLOGY

Westin, J; Lagging, LM; Dhillon, AP; Hellstrand, K; Norkrans, G; Romero, A; ... Neumann, AU; + view all (2005) Steatosis does not affect the result of antiviral treatment in HCV genotype 3 infected patients. In: JOURNAL OF HEPATOLOGY. (pp. 227 - 227). ELSEVIER SCIENCE BV

Westwood, MA; Wonke, B; Maceira, AM; Prescott, E; Walker, JM; Porter, JB; Pennell, DJ; (2005) Left ventricular diastolic function compared with T2*cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major. J MAGN RESON IMAGING , 22 (2) 229 - 233. 10.1002/jmri.20379.

Whelan, JS; (2005) Osteosarcoma. In: Eden, OB and Barr, R and Bleyer, A and Whiteson, M, (eds.) Cancer and the Adolescent. Blackwell Publishing: Oxford.

Whelan, JS; McTiernan, AM; Weston, C; Ahrens, S; Grimer, R; Lewis, I; ... Craft, A; + view all (2005) Differences in survival between Study Groups detected in an international randomised study: analysis of Eicess 92. In: Sarcoma Meeting Stuttgart, June, 2005. Sarcoma 2005; 9(1/2): 115 (P177).

Williams, DR; Reardon, K; Roberts, L; Dennet, X; Duff, R; Laing, NG; Byrne, E; (2005) A new dominant distal myopathy affecting posterior leg and anterior upper limb muscles. Neurology , 64 (7) 1245 - 1254.

Williams, GH; Eward, KL; Kingsbury, SR; Okorokov, AL; Stoeber, K; (2005) Geminin is a critical regulator of growth in human somatic and germ cells. In: JOURNAL OF PATHOLOGY. (pp. 39 - 39). JOHN WILEY & SONS LTD

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 57 - 57). BLACKWELL PUBLISHING

Wilson, GA; Bertrand, N; Patel, Y; Hughes, JB; Feil, EJ; Field, D; (2005) Orphans as taxonomically restricted and ecologically important genes. Microbiology , 151 (Pt 8) 2499 - 2501.

Wilson, JRF; Pathak, H; Staff, AC; Harsem, NK; Braekke, K; Rees, MCP; ... Nikitenko, LL; + view all (2005) Expression of adrenomedullin and its receptor in third trimester placental bed decidua from normal and pre-eclamptic pregnancies. PLACENTA , 26 (8-9) A54 - A54.

Winter, M; Keeling, D; Sharpen, F; Cohen, H; Vallance, P; Haemostasis,; Thrombosis Task Force of the British Committee for Standards in, H; (2005) Procedures for the outpatient management of patients with deep venous thrombosis. Clinical and laboratory haematology , 27 61 - 66.


Yousaf, N; Gould, DJ; Aganna, E; Hammond, L; Mirakian, RM; Turner, MD; ... Chernajovsky, Y; + view all (2005) Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis Rheum , 52 (9) 2906 - 2916. 10.1002/art.21268.


Zhang, X; Odom, DT; Koo, SH; Conkright, MD; Canettieri, G; Best, J; ... Montminy, M; + view all (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A , 102 (12) 4459 - 4464. 10.1073/pnas.0501076102.

This list was generated on Sun Jun 28 03:52:36 2015 BST.